HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 multipeptide vaccine

Definition / meaning of HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 multipeptide vaccine

A cancer vaccine containing four HLA-A*0201-restricted peptide epitopes with potential immunostimulatory and antitumor activities. Vaccine peptide epitopes are derived from the tumor associated antigens (TAAs) tyrosinase-related protein 2 (TRP2), glycoprotein 100 (gp100), Ephrin receptor A2 (EphA2) and human epidermal growth factor receptor 2 (HER2). Upon administration, HLA-A*0201-restricted TRp2-gp100-EphA2-HER2 multipeptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against TRP2-gp100-EphA2-HER2-expressing tumor cells, resulting in tumor cell lysis and decreased tumor cell proliferation. HLA-A*0201 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*0201 may improve antigenic peptide immunogenicity.

Listed under:

Find More About 'HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 multipeptide vaccine'


The Web site of the National Cancer Institute (http://www.cancer.gov/drugdictionary)

Leave a Comment


This site uses Akismet to reduce spam. Learn how your comment data is processed.